Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2023 | The first network of multidomain dementia prevention: World-Wide FINGER trials

Alina Solomon, MD, PhD, University of Eastern Finland, Kuopio, Finland, provides insights into the remarkable growth of the World-Wide FINGER network, a pioneering initiative in multidomain dementia prevention trials. Launched in 2009 in Finland, the proof-of-concept FINGER trial was designed to study the impact of lifestyle interventions on cognitive decline and dementia risk, demonstrating the significant benefit of a combined approach addressing diet, exercise, cognitive training, and vascular risk monitoring. Originally, the FINGER intervention was implemented in only a handful of countries, but it quickly gained global recognition. Currently, the package is being adapted and tested in more than 60 countries, encompassing diverse populations and settings. Notably, this expansion extends to low to middle income countries, widening the reach of these interventions. The expansion of the World-Wide FINGER network establishes it as the world’s first global network dedicated to multidomain dementia prevention trials. This interview took place at the Alzheimer’s Association International Conference® (AAIC) 2023 in Amsterdam, Netherlands.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.